Secondary malignancies after treatment with single-agent vemurafenib in two patients with refractory hairy cell leukemia.

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemia.

Spontaneous Iliopsoas Muscle Hemorrhage Secondary to Ibrutinib (Imbruvica; Pharmacyclics): Brief Report.

Current Therapy and New Directions in the Treatment of Hairy Cell Leukemia: A Review.

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Retrospective analysis of relative dose intensity in patients with non-Hodgkin lymphoma receiving CHOP-based chemotherapy and pegfilgrastim.

Hairy cell leukemia: a 'hair-raising' update.

Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series.